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Abstract
The mechanisms contributing to multiorgan dysfunction during cardiogenic shock are poorly understood. Our goal was to
characterize the microcirculatory and mitochondrial responses following $10 hours of severe left ventricular failure and
cardiogenic shock. We employed a closed-chest porcine model of cardiogenic shock induced by left coronary
microembolization (n = 12) and a time-matched control group (n = 6). Hemodynamics and metabolism were measured
hourly by intravascular pressure catheters, thermodilution, arterial and organ specific blood gases. Echocardiography and
assessment of the sublingual microcirculation by sidestream darkfield imaging were performed at baseline, 261 and 1363
(mean6SD) hours after coronary microembolization. Upon hemodynamic decompensation, cardiac, renal and hepatic
mitochondria were isolated and evaluated by high-resolution respirometry. Low cardiac output, hypotension, oliguria and
severe reductions in mixed-venous and hepatic O2 saturations were evident in cardiogenic shock. The sublingual total and
perfused vessel densities were fully preserved throughout the experiments. Cardiac mitochondrial respiration was
unaltered, whereas state 2, 3 and 4 respiration of renal and hepatic mitochondria were increased in cardiogenic shock.
Mitochondrial viability (RCR; state 3/state 4) and efficiency (ADP/O ratio) were unaffected. Our study demonstrates that the
microcirculation is preserved in a porcine model of untreated cardiogenic shock despite vital organ hypoperfusion. Renal
and hepatic mitochondrial respiration is upregulated, possibly through demand-related adaptations, and the endogenous
shock response is thus compensatory and protective, even after several hours of global hypoperfusion.
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Introduction
Cardiogenic shock (CS) is the result of a complex process with
failure of O2 delivery, generalized ATP deficiency, and multiorgan
dysfunction initiated by cardiac pump failure [1]. CS complicates
2–10% of acute coronary syndromes and is the leading cause of
death among these patients, with a short-term mortality of 40–
80% [2]. Several large trials have demonstrated that coronary
revascularization is the most important strategy to improve patient
survival [3–5]. However, patients who develop CS despite acute
revascularization have a poor prognosis [6–8].
Interestingly, microcirculatory and mitochondrial dysfunction
has been linked to the prognosis in septic shock [9], and several
lines of research have led to the concept of a microcirculatory and
mitochondrial dysfunction syndrome [10–12]. However, the
support for such a syndrome in cardiogenic shock is more vague.
Using venous plethysmography, Kirschenbaum et al. showed that
forearm blood flow at rest and reactive hyperemia were
diminished in a small subset of CS patients [13]. Reductions in
the proportion of perfused small vessels and perfused capillary
density have also been observed in patients with CS using
orthogonal polarization spectral and sidestream darkfield imaging
(SDF) imaging [14,15]. However, mortality has also been observed
in CS patients with unaltered microcirculation [15]. Finally,
although cardiac mitochondria are impaired in left ventricular
failure [16–18], extracardiac mitochondrial function has not been
studied in pure pump-failure CS.
In this study, an experimental model without drug treatment
was established to assess microcirculatory and mitochondrial
responses to CS. We examined microcirculatory function, organ
metabolism and mitochondrial respiration in a porcine model of
acute left ventricular dysfunction and CS induced by coronary
microembolization (CME). We show that sublingual microcircu-
latory function was well preserved during the acute phase
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following induction of shock and that a compensatory upregula-
tion of renal and hepatic mitochondrial respiration occurred
despite severe systemic hypoperfusion.
Materials and Methods
The experimental protocol was approved by the local steering
committee of the Norwegian Animal Research Authority and was
conducted in accordance with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996). 18 castrated
male domestic pigs (Norwegian Landrace and Yorkshire hybrids)
weighing 4963 kg were adapted to the animal facilities for 4–7
days and fasted overnight before the experiment with free access to
water.
Anesthesia and instrumentation
The animals were premedicated with 20 mg/kg ketamine,
0.5 mg/kg midazolam and 0.03 mg/kg atropine administered
intramuscularly. General anesthesia was induced with 0.01 mg/kg
fentanyl and 10 mg/kg sodium pentobarbital through an ear vein
and maintained with 0.02 mg/kg/h fentanyl, 4 mg/kg/h sodium
pentobarbital and 0.3 mg/kg/h midazolam through a central
venous catheter. The animals were intubated and mechanically
ventilated using a volume-controlled ventilator adjusted according
to capnography and arterial blood gases. The circulating volume
was maintained by a 10 ml/kg/h saline infusion. 2500 IU heparin
and 6 mg/kg amiodarone were administered to avoid catheter
clotting and malignant arrhythmias. Arterial blood glucose was
maintained at 4–6 mmol/l by infusion of 20% glucose as required.
A normal core temperature was maintained at 38uC using a
thermal mattress. A series of introducer sheaths were placed in the
external jugular veins, femoral arteries and veins to facilitate
vascular recordings and interventions as follows: I) A 7 Fr
thermodilution catheter through the left external jugular vein to
measure central venous pressure (CVP), mean pulmonary artery
pressure (MPAP), pulmonary artery occlusion pressure (PAOP),
cardiac index (CI), mixed venous O2 saturation (SvO2), and core
temperature; II) Measurement of mean arterial pressure (MAP)
and arterial blood sampling. III) Coronary artery catheterization,
fluoroscopy and microembolization. IV) Catheters inserted via
both femoral veins and advanced with fluoroscopic guidance into
the hepatic vein and the left renal vein to obtain blood samples. A
10 Fr suprapubic catheter was used to drain the urinary bladder.
Experimental protocol
The experiments were performed in an alternating manner
between shock (n = 12) and time-matched controls (n = 6).
Echocardiographic and microcirculatory recordings were obtained
at baseline, 2 hours after CME, and $10 hours after CME, closely
preceding circulatory collapse. The main trunk of the left coronary
artery was catheterized with a 4 Fr angiography catheter under
fluoroscopic guidance, and CME was performed using 50 mm
polystyrene microspheres (Chromosphere, Duke Scientific Corpo-
ration) dissolved in 0.9% sodium chloride and 0.01% Tween 80.
The degree of contractile dysfunction was titrated to a 30%
decrease in CI through repeated injections of 10–15 mg every 5–
10 min. The prespecified inclusion criteria for the CS group were:
I) $30% acute reduction in CI; II) hypotension with MAP,
65 mmHg or systolic pressure ,90 mmHg; III) hypoperfusion as
evidenced by oliguria/anuria; and IV) an observation time of $10
hours following CME. After the final measurements were
performed, tissue samples were collected from the liver, the right
kidney and the left ventricle, and the animals were euthanized with
an intravenous injection of 20 mg/kg sodium pentobarbital.
Speckle tracking echocardiography
Left ventricular short-axis transthoracic 2D images were
acquired using a 5–12 MHz probe and a Philips iE33 ultrasound
scanner (Philips Medical Systems). High frame rates (90–100 Hz)
were achieved without a reduction in spatial resolution using a
narrow image-sector angle and maximal zooming. Aortic flow was
acquired by Doppler, and the timing of aortic valve opening and
closure was determined to calculate strain in the ejection period.
The 2D images were analyzed using dedicated offline software
(Syngo Velocity Vector Imaging, Siemens Medical Systems). The
software acquired and averaged three cardiac cycles. Short-axis
2D images were divided into 6 regions of interest with 8 tracked
points per region of interest. Strain and strain rate values were
determined at the time of aortic valve closure. Strain was defined
by the Lagrangian formula e= (L2L0)/L0 =DL/L0 where e is
strain, L0 is the initial length, and L is the instantaneous length.
Furthermore, strain is expressed as the percentage of initial length
such that positive values are observed with lengthening or
thickening (i.e. radial thickening), and negative values are observed
with shortening (i.e. longitudinal and circumferential shortening).
Strain rate was defined as e9 =D e/Dt where e9 is strain rate, and t
is time [19]. All 2D images were assessed for quality prior to
inclusion and image analysis, and the correct tracking of endo- and
epicardial borders was controlled visually.
Microcirculatory recordings and analysis
The sublingual microcirculation was evaluated using SDF
imaging with a 56 objective lens (Microscan, Microvision
Medical), and image analysis was conducted using a commercially
available software package (Automated Vascular Analysis, Micro-
vision Medical). At each measurement, steady images lasting $20
seconds were obtained from 5–10 sublingual areas, with care taken
to avoid pressure artifacts by ensuring that venular flow was
present throughout the recording [20]. SDF images were recorded
electronically for offline analysis. All discernible vessels were
manually demarcated in the microcirculatory video recordings
according to current guidelines [20]. The total vessel density
(TVD; mm/mm2) was calculated as the total length of vessels
divided by the total surface area. Perfusion was qualitatively
described as present (continuous flow for $20 seconds), absent (no
flow for $20 seconds) or intermittent (no flow $50% of the time).
Vessels with diameters less than 20 mm were defined as small
vessels. Three equidistant horizontal and vertical lines were drawn
on the recorded area, and the proportion of perfused small vessels
(PPV) was calculated as the number of perfused small vessels
(continuous flow $20 seconds) crossing the lines divided by the
total number of small vessels crossing the lines. Perfused vessel
density (PVD; mm/mm2), an estimate of functional capillary
density, was calculated by multiplying the small vessel density by
the proportion of perfused small vessels. The predominant type of
small vessel flow (0 = absent, 1 = intermittent, 2 = sluggish, and
3 = normal) in each quadrant was assessed, and the microvascular
flow index (MFI) was calculated as the averaged value from all four
quadrants [21]. To obtain mean values at each measurement
point, the data from 5 sublingual areas were averaged. The images
used for these analyses were selected according to sharpness and
the absence of movement artifacts to optimize image quality.
Mitochondrial high-resolution respirometry
Cardiac subsarcolemmal (SSM) and interfibrillar mitochondria
(IFM) were isolated from the left ventricle as previously described
Microcirculation and Mitochondria in Cardiogenic Shock
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e105213
[22,23]. Renal and hepatic mitochondria were also isolated by the
procedure used to isolate SSM mitochondria. Mitochondrial
respiration was measured using a Clark-type electrode (Oxygraph-
2k, Oroboros Instruments). Complex 1-dependent respiration was
assessed using glutamate and malate as substrates. Complex 2-
dependent respiration was assessed using succinate as a substrate,
and rotenone was added to inhibit complex 1 activity. The initial
O2 consumption after the addition of mitochondria and substrate
was recorded as state 2. State 3 respiration was obtained after the
addition of ADP to a final concentration of 300 mM, and state 4
resting respiration was measured after the added ADP was
depleted. The respiratory control ratio (RCR; state 3/state 4) was
calculated as described by Chance et al. [24]. The ADP to oxygen
(ADP/O) ratio was calculated based on the addition of a known
amount of ADP and the associated O2 consumption. Mitochon-
drial protein concentration was determined by the Bradford
method using bovine serum albumin as a standard [25]. Citrate
synthase specific activity was calculated spectrophotometrically
[26].
Statistics
Hemodynamic and metabolic data are presented as mean6SD,
whereas microcirculatory and mitochondrial data are presented as
median6range. Hemodynamic, echocardiographic, metabolic
and microcirculatory data were analyzed using a linear mixed-
models approach with a restricted maximum likelihood method
and the subject identifier as the random effect. Within-group
trends that were not identified as significant using linear mixed-
models were also assessed by one-way repeated measurements
analysis of variance. P-values were adjusted for multiple compar-
isons using Tukey’s test. Mitochondrial respiratory data were
assessed using the Mann-Whitney U-test. P-values ,0.05 were
regarded as statistically significant, and all analyses were conduct-
ed in JMP 9.0 (SAS Institute).
Results
A total of 18 animals were used in this study. CME was
performed in 12 animals, while 6 animals served as time-matched
controls. Of the animals subjected to CME, 3 animals died shortly
after CME due to fatal cardiac arrhythmia and abrupt circulatory
collapse, 2 animals failed to develop low cardiac output, and 1
animal did not show evidence of hypoperfusion. Thus, 6 animals
did not fulfill the inclusion criteria and were excluded. Acute
measurements after CME were performed when the animals
exhibited a hemodynamic steady state (261 hours), and the final
in vivo measurements were performed 1363 hours after CME.
This time point closely preceded decompensation and cardiovas-
cular collapse, and most animals in the shock group died during
the interval of interest due to circulatory instability, escalating and
ultimately fatal arrhythmias.
Hemodynamics and metabolism
The groups were similar at baseline with respect to hemody-
namic, metabolic and microcirculatory parameters. The micro-
sphere dose used to induce left ventricular (LV) failure was
67619 mg. As shown in Figure 1, the stroke volume index
decreased to approximately 1/3 of the baseline value. LV failure
was also evident by the increases in MPAP and PAOP. CVP
increased in the shock group (761 vs. 1262 mmHg, p,0.05).
Despite compensatory tachycardia, an acute and sustained 40%
reduction in CI was observed. Hypotension and oliguria/anuria
developed gradually. The systemic vascular resistance (SVR) was
similar between groups throughout the experiment. The systemic
O2 delivery was reduced by approximately 50% in CS (6.561.7,
ml/min/kg) compared with baseline and control group values
(12.962.6 and 13.462.7, both p,0.05), whereas the systemic O2
consumption was unaltered. Figure 2 shows that both mixed and
organ-specific venous O2 saturations declined substantially, with
hepatic O2 saturation as low as 3%, indicating an extreme
extraction across the liver, while no increase in arterial lactate
concentration was observed. Similarly, there was no increase in
renal and hepatic venous lactate levels (data not shown).
Speckle tracking echocardiography
Short-axis transthoracic 2D images were excluded from speckle
tracking analysis in 1 shock and 2 control animals due to technical
reasons. The average LV strain and strain rate in the shock group
tended to decrease in the radial dimension and increase in the
circumferential dimension, implying impaired contractility (Figure
S1). The anteroseptal and lateral regions of interest were most
severely affected by CME, and there was no evidence of
compensatory hyperkinesia in regions supplied by the right
coronary artery (Video S1).
Microcirculatory function
The sublingual total large vessel density, small vessel density,
proportion of perfused small vessels and microvascular flow index
did not change throughout the experiment in either group, and the
shock group exhibited no detectable defects in microcirculatory
function as assessed by SDF (Figure 3). Recordings from a pilot
experiment are presented in Video S2, demonstrating no
difference in microcirculatory parameters during shock. Further-
more, the effect of administering high-dose arginine-vasopressin
on the microcirculation is demonstrated in the video to illustrate
the sensitivity of SDF imaging in detecting potential alterations in
microcirculatory function.
Mitochondrial respiration
LV, renal and hepatic mitochondria were isolated from all
animals. Measurements of complex 2-dependent respiration in
SSM from 1 control animal and 1 shock animal were excluded
from analysis due to technical issues, thus n = 5 for these
measurements. The respiratory rates were normalized to citrate
synthase activity in the samples to permit the comparison of
measurements from different suspensions of isolated mitochondria.
All measurements were also compared after adjustment for the
total protein content, with similar results.
Complex 1-dependent respiration in the cardiac IFM and SSM
fractions were unaffected by CME, whereas complex 1-dependent
renal and hepatic state 2, 3 and 4 respiratory rates were
significantly elevated following CME (Table 1). The complex 2-
dependent respiratory rates in the cardiac IFM and SSM fractions
were also similar between groups. Complex 2-dependent hepatic
state 2 and renal state 3 and 4 respiratory rates were significantly
elevated in the shock group. Mitochondrial coupling and viability,
as assessed by the RCR, were similar between groups. The ADP/
O ratio was also unaffected by CME, indicating a similar
mitochondrial efficiency and thus no difference in non-metabolic
O2 consumption between groups.
Biochemistry
The level of circulating leukocytes was similar in both groups
across all time points, indicating the absence of any major systemic
inflammatory response. Creatinine levels were increased in the
shock group, corresponding to the development of oliguria and
kidney failure. Aspartate and alanine transaminase levels both
Microcirculation and Mitochondria in Cardiogenic Shock
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increased in the shock group, with the latter indicating hepato-
cellular damage (Figure 4). Cardiac troponin T levels increased to
5.862.8 mg/l 1363 hours after CME, whereas they remained
below the detection limit (0.01 mg/l) in the control group.
Discussion
In these healthy young animals, the reduced systemic O2
delivery in the acute phase of experimental CS is counteracted by
microcirculatory and mitochondrial adaptations and this periph-
Figure 1. Hemodynamics. A–D: Mean arterial pressure (MAP), cardiac index (CI) and stroke volume index (SVI) decreased following coronary
microembolization (CME). Diuresis gradually declined, and all shock-treated animals developed oliguria/anuria. E–F: A profound increase in heart rate
(HR) developed after CME. Mean arterial pulmonary pressure (MPAP) and pulmonary artery occlusion pressure (PAOP) both increased after CME due
to severe left ventricular dysfunction. The systemic vascular resistance (SVR) was unaffected by CME. The data are presented as mean6SD. Open
circles, time-matched control group; filled circles, cardiogenic shock group. * p,0.05 within group compared to baseline, {p,0.05 within group
compared to 261 hours, `p,0.05 between groups.
doi:10.1371/journal.pone.0105213.g001
Figure 2. Metabolism. A–C: Mixed venous, renal venous and hepatic venous O2 saturations (SO2) were reduced following coronary
microembolization. D: No increase in arterial lactate was observed despite profound shock. The data are presented as mean6SD. Open circles, time-
matched control group; filled circles, cardiogenic shock group. * p,0.05 within group compared to baseline, {p,0.05 within group compared to 261
hours, `p,0.05 between groups.
doi:10.1371/journal.pone.0105213.g002
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eral adaptability is sufficient to withstand anaerobic metabolism
despite prolonged severe hypoperfusion. CME induced severe
decreases in stroke volume index, low CI, hypotension and a
gradual onset of oliguria/anuria. This untreated CS was ultimately
fatal. Despite acute and prolonged hypotension, the SVR was
unaltered in the shock group. This has been observed by others
both experimentally and clinically and challenges the classical
paradigm of CS [27–29]. We found no biochemical indication of
Figure 3. Total and Perfused Small Vessel Densities. A–B: The total small vessel density (TVD) and perfused small vessel density (PVD) were
fully preserved after coronary microembolization (CME). C: The proportion of perfused small vessels (PPV) was also identical across time points and
between groups. D: The microvascular flow index (MFI) was not affected by CME. The data are presented as median6range. Open box plots, time-
matched control group; filled box plots, cardiogenic shock group.
doi:10.1371/journal.pone.0105213.g003
Table 1. Mitochondrial Respiratory Parameters.
Organ
Substrate Group Cardiac IFM Cardiac SSM Renal Hepatic
Glutamate
State 2 Control 59 (39–65) 38 (22–44) 90 (78–104) 77 (53–86)
Shock 50 (14–80) 27 (15–36) 116 (105–132)` 94 (79–142)`
State 3 Control 434 (241–473) 393 (246–700) 955 (678–1138) 947 (391–1193)
Shock 311 (73–702) 222 (101–517) 1371 (1103–1885)` 1275 (1124–1987)`
State 4 Control 88 (62–104) 56 (39–84) 89 (76–108) 59 (53–104)
Shock 105 (68–180) 62 (55–62) 110 (105–149)` 116 (102–160)`
RCR Control 4.6 (3.9–7.6) 6.8 (4.9–9.7) 10.4 (8.4–11.5) 10.4 (7.5–12.5)
Shock 2.7 (1.1–6.3) 3.7 (1.6–8.8) 12.5 (10.1–13.1) 12.0 (9.4–12.5)
ADP/O Control 2.9 (2.7–3.1) 2.8 (2.7–3.0) 2.6 (2.4–2.9) 2.7 (2.5–3.1)
Shock 2.0 (1.5–3.0) 2.5 (2.1–3.0) 2.6 (2.4–2.9) 2.8 (2.5–2.9)
Succinate
State 2 Control 165 (103–221) 131 (92–283) 353 (304–416) 208 (161–228)
Shock 154 (50–269) 82 (39–128) 415 (379–474) 249 (198–352)`
State 3 Control 345 (210–406) 336 (190–541) 1752 (1560–1953) 1531 (1209–1862)
Shock 267 (91–550) 199 (99–338) 2440 (2018–2516)` 1892 (1344–2614)
State 4 Control 148 (114–254) 148 (98–329) 212 (137–224) 232 (156–255)
Shock 168 (85–297) 113 (83–128) 253 (189–335)` 275 (225–394)
RCR Control 1.8 (1.6–2.3) 2.2 (1.6–3.0) 8.7 (7.5–12.5) 7.3 (6.0–8.0)
Shock 1.5 (1.1–2.1) 2.0 (1.2–2.7) 9.1 (7.3–11.0) 6.5 (5.8–7.9)
ADP/O Control 1.7 (1.6–2.1) 1.8 (1.4–2.1) 1.8 (1.7–2.0) 1.9 (1.6–2.0)
Shock 1.2 (0.1–1.8) 1.7 (0.4–1.9) 1.9 (1.8–2.0) 1.9 (1.8–2.0)
Renal and hepatic complex 1-dependent state 2, 3 and 4 mitochondrial respiration using glutamate as substrate were increased in cardiogenic shock, whereas respiratory
control ratio (RCR) and ADP/O values were unaffected indicating well-coupled and efficient respiration. Cardiac interfibrillar (IFM) and subsarcolemmal (SSM) mitochondrial
respiration was unaffected. Complex 2-dependent mitochondrial respiration using succinate as substrate demonstrates a similar tendency. State 2, 3 and 4 respiratory rates
are presented as pmol O2/min/IU citrate synthase. The data are presented as median6range.
`p,0.05 between groups.
doi:10.1371/journal.pone.0105213.t001
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an acute inflammatory response as a potential counteraction of the
classical sympaticoneural vasoconstriction, but a systemic inflam-
matory response could still contribute to the lack of a vasocon-
strictive response.
Microvascular dysfunction has been implicated in the patho-
physiology of CS in small-sample studies of CS patients [13,14]. In
a study of 68 patients with CS following acute myocardial
infarction, below median sublingual perfused capillary densities
were associated with the development of multiorgan failure and
poor outcomes [15]. From a pathophysiological point of view, it is
difficult to appreciate the significance of this observation. The
study population was heterogeneous, and the patients were treated
with inotropes, vasoactive drugs and mechanical assist systems.
Thus, the microvascular impairment in these patients may have
been an epiphenomenon associated with the treatment modalities,
which is of limited relevance to the underlying pathophysiological
cascades. In support of this theory, small vessel flow has been
shown to improve upon the withdrawal of intraaortic balloon
counterpulsation in patients weaned from mechanical support
[30]. Also, vasopressor addition profoundly affected the microcir-
culatory function in our experimental model, as shown by Video
S2. We observed no detectable microcirculatory dysfunction in
untreated and severe CS, and the sublingual total large vessel
density, small vessel density, proportion of perfused small vessels
and microvascular flow index were fully preserved throughout the
experiment. Interestingly, these findings could be related to the
observed upregulation of mitochondrial function, as the metabolic
demand is maintained. During sepsis, diminished tissue O2
consumption and a parallel increase in tissue O2 levels are caused
by mitochondrial dysfunction [31], in turn reducing the levels of
vasodilating metabolites and thus possibly contributing to
decreased microvascular flow. Similar alterations with reduced
microvascular flow and perfused capillary density are observed in
normobaric hyperoxia, indicating that O2 availability may control
microvascular perfusion [32]. Thus, our data, which demonstrate
the full maintenance of microcirculatory function during CS, can
be explained by tissue hypoxia concurrent with unimpeded
mitochondrial metabolism and thus high O2 demand.
The effect of CS on extracardiac mitochondrial function has
received limited attention. CS is characterized by several
detrimental processes, with inflammation, hypoxia and ischemia-
reperfusion all contributing to systemic cellular injury [33]. As
stated, in the present study, however, we observed no indication of
any major systemic inflammatory response. In contrast, assessment
of the O2 saturation in the parenchymal venous drainage revealed
organ hypoxia to such an extent that enzyme leaks were present.
Thus, the effects of hypoxia could parallel organ pathology in CS.
Notably, state 3 respiratory rate in cardiac mitochondria has been
found to increase more than 100% during acute in vivo
hypoxemia and to stabilize at more than 40% above baseline
during chronic in vivo hypoxemia [34]. A similar observation has
been made following hypoperfusion [35,36], and comparable
effects were also observed when demand was increased by
endurance training [37,38]. Hypoxia activates hypoxia-inducible
factor 1 (HIF-1) through increased generation of reactive oxygen
species (ROS). HIF-1 initiates a potentially adaptive response
where increased glycolytic flux and pyruvate-lactate conversion,
impaired tricarboxylic-acid-cycle activity and altered composition
of cytochrome c oxidase (COX, complex 4) in the electron
transport chain ensures an efficient ATP production without
excessive ROS generation [39]. Noticeably, through subunit
conversion from COX4-1 to COX4-2, O2 consumption and ATP
production increases under hypoxic conditions, whereas H2O2
levels decrease [40]. These changes in mitochondrial oxidative
phosphorylation capacity appear to be adaptive and imply that
mitochondrial efficiency is increased under hypoxic conditions.
Similar mechanisms may increase ATP production due to
increased demand following acute exposure to inflammatory
cytokines [41]. However, in vitro exposure of isolated mitochon-
dria to hypoxic conditions produces variable effects on respiratory
activity [42,43], and it is likely that these demand-related
adaptations are caused, at least in part, by extramitochondrial
interactions [44,45].
We observed an increase in renal and hepatic state 3 respiratory
rates in CS using complex 1-dependent substrates, whereas this
parameter was unaltered in both cardiac fractions. Renal and
hepatic state 2 and 4 respiratory rates were slightly increased in the
shock group, but the RCR values and ADP/O ratios were similar,
indicating well-coupled and efficient respiration. A similar trend
was observed when succinate was used as a complex 2-dependent
substrate, but only renal state 3 respiratory rate was significantly
elevated in the shock group. Cardiac respiratory data were highly
variable, and this likely reflects the heterogeneous pattern of
microinfarctions after CME [46]. Prior studies have demonstrated
Figure 4. Indicators of Organ Damage. A: Circulating leukocyte levels were similar between groups, indicating the absence of any major
inflammatory response after coronary microembolization (CME). B: Creatinine levels increased following CME, in parallel with the kidney failure
evidenced by oliguria/anuria. C–D: Hepatic aspartate (AST) and alanine (ALT) transaminase levels increased after CME, indicating hepatocellular
damage. The data are presented as median6range. Open box plots, time-matched control group; filled box plots, cardiogenic shock group. * p,0.05
within group compared to baseline, {p,0.05 within group compared to 261 hours, `p,0.05 between groups.
doi:10.1371/journal.pone.0105213.g004
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decreased respiratory rates in both the ischemic and remote
myocardium [17,18], and this has been linked to reduced levels of
the supercomplex 1/3-dimer/4, together with increased phos-
phorylation of complex 4 subunits [18,47]. Cardiac mitochondrial
dysfunction and energetic failure are thus potentially important
mechanisms propagating contractile failure during cardiogenic
shock [16,48,49].
This study has several limitations when exploring potential
mechanisms of human cardiogenic shock. The porcine model used
young animals without comorbid disease and with substantial
compensatory reserves. The unresuscitated observation period
following the induction of shock is of limited duration, and it is
possible that a longer observation phase, or an active treatment
protocol, could have uncovered both microcirculatory and
mitochondrial dysfunction. The methods used to isolate mito-
chondria from various tissues were designed to exclude damaged
mitochondria and preserve the viable mitochondria. Thus, existing
mitochondrial dysfunction in vivo may remain undetected.
However, we observed no differences in total protein content or
citrate synthase activity among groups, indicating that the
amounts of mitochondria isolated from each group were similar.
In cardiac biopsies, however, the loss of damaged mitochondria
due to the isolation procedure likely contributed to the observed
results. Furthermore, only two substrate combinations were used
in the experiments. Glutamate and malate were used to observe
complex 1-dependent respiration, and succinate was used as a
substrate for complex 2-dependent respiration. Oligomycin was
not used to inhibit ATP-synthase, but a stable state 4 was observed
following ADP depletion. Thus, the use of other substrates may
reveal differences between CS and controls that remained
undetected in the present study.
In conclusion, we demonstrate that the microcirculation is
preserved in a porcine model with untreated CS despite vital
organ hypoperfusion. Renal and hepatic mitochondrial respiration
is upregulated, possibly through demand-related adaptations, and
the endogenous shock response appears to be compensatory and
protective, even after several hours of global hypoperfusion.
Supporting Information
Figure S1 Strain and Strain Rate. A–B: The average radial
strain across all regions of interest decreased after coronary
microembolization (CME), whereas a similar left ventricular
dysfunction was evident by the increase in the average
circumferential strain. C–D: The average circumferential strain
rate also increased after CME. Data are presented as median6-
range. Open box plots, time-matched control group; filled box
plots, cardiogenic shock group. *p,0.05 within group compared
to baseline by one-way repeated measurements analysis of
variance.
(EPS)
Video S1 Example echocardiography recordings. Short-
axis transthoracic 2D images from a cardiogenic shock animal at
baseline, after coronary microembolization and during cardiogen-
ic shock.
(M4V)
Video S2 Example microcirculatory recordings. Side-
stream darkfield images from a pilot experiment at baseline,
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